The performance characteristics of the impact crusher independently developed by our company

The impact crusher independently developed by our company features impact crusher which can be divided into hammer type and counter type. The hammer crusher uses high-speed rotating hammer and the material itself crashes into the liner and breaks when the material reaches the grain size requirement. After being discharged from the gap of the lower screen strip, the hammer crusher is suitable for medium and fine crushing of medium hardness and brittle materials. It has the advantages of high production efficiency, large crushing ratio, simple structure, compact size, low power consumption, and simple maintenance. . The impact crusher is rotated by the rotor at a high speed. After the material enters, it collides with the plate hammer on the rotor and then it is broken. Then it is counterattacked and crashed into the liner again and discharged from the discharge port. Impact crusher combines impact, counterattack, centrifugal impact, shear, and grinding together. It has the characteristics of high crushing efficiency, fine and uniform material discharge, less vulnerable parts, convenient maintenance, and low energy consumption. Currently, impact crushers are divided into vertical and horizontal types. Self-percussion crusher consists of vortex crushing cavity, feeding and distributing device, rotor vortex cutter, power transmission device and frame. Self-percussion crushers use the crushing between stone and stone. A part of the stone obtains kinetic energy through a high-speed rotating device, and the other part is impacted and broken by falling stones. The stone in the crushing cavity is formed into a stone-lined self-lining. The prominent features of the self-impact crusher are mainly the crushing between the stone and the stone, which greatly reduces the wear and tear of the equipment, reduces maintenance, and prolongs the life of the equipment.

Abemaciclib Intermediates

Abemaciclib is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. Abemaciclib specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of the serine/threonine kinases CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation.

Abemaciclib Cas 1180132-17-5,Abemaciclib Cas 1231930-42-9,Abemaciclib Cas 1231930-37-2,Abemaciclib Cas 67567-26-4

 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com